Published in Nephrol Dial Transplant on November 07, 2007
Feasibility Study of Arterial Stiffness in Hemodialysis Patients | NCT02196610
Effect of A Reduction in glomerular filtration rate after NEphrectomy on arterial STiffness and central hemodynamics: rationale and design of the EARNEST study. Am Heart J (2013) 2.07
Left ventricular twist mechanics and its relation with aortic stiffness in chronic kidney disease patients without overt cardiovascular disease. Cardiovasc Ultrasound (2016) 1.40
Central aortic blood pressure, augmentation index, and reflected wave transit time: reproducibility and repeatability of data obtained by oscillometry. Vasc Health Risk Manag (2011) 1.04
Arterial stiffness is associated with cardiovascular, renal, retinal, and autonomic disease in type 1 diabetes. Diabetes Care (2012) 0.95
Assessments of arterial stiffness and endothelial function using pulse wave analysis. Int J Vasc Med (2012) 0.90
Plasma concentrations of extracellular matrix protein fibulin-1 are related to cardiovascular risk markers in chronic kidney disease and diabetes. Cardiovasc Diabetol (2013) 0.89
Arterial stiffness and chronic kidney disease: lessons from the Chronic Renal Insufficiency Cohort study. Curr Opin Nephrol Hypertens (2015) 0.86
Intradialytic versus home-based exercise training in hemodialysis patients: a randomised controlled trial. BMC Nephrol (2009) 0.86
Eplerenone attenuates pulse wave reflection in chronic kidney disease stage 3-4--a randomized controlled study. PLoS One (2013) 0.84
Quantification of aortic stiffness using magnetic resonance elastography: Measurement reproducibility, pulse wave velocity comparison, changes over cardiac cycle, and relationship with age. Magn Reson Med (2015) 0.83
Effects of bone and mineral metabolism on arterial elasticity in chronic renal failure. Pediatr Nephrol (2009) 0.79
Arterial applanation tonometry: feasibility and reproducibility in children and adolescents. Am J Hypertens (2014) 0.79
Galectin 3: association to neurohumoral activity, echocardiographic parameters and renal function in outpatients with heart failure. BMC Cardiovasc Disord (2016) 0.77
The impact of the aortic pulse wave velocity on the cardiovascular outcomes of hemodialysis patients. J Korean Med Sci (2009) 0.77
The impact of intervention strategies that target arterial stiffness in end-stage renal disease: a systematic review protocol. Syst Rev (2016) 0.77
Large Artery Stiffness Assessment Using SphygmoCor Technology. Pulse (Basel) (2016) 0.77
The Effect of High Dose Cholecalciferol on Arterial Stiffness and Peripheral and Central Blood Pressure in Healthy Humans: A Randomized Controlled Trial. PLoS One (2016) 0.75
Development of a Standard Protocol for the Harmonic Analysis of Radial Pulse Wave and Assessing Its Reliability in Healthy Humans. IEEE J Transl Eng Health Med (2015) 0.75
A randomized control trial to assess the impact of vitamin D supplementation compared to placebo on vascular stiffness in chronic kidney disease patients. BMC Cardiovasc Disord (2014) 0.75
Reproducibility of carotid-femoral pulse wave velocity in end-stage renal disease patients: methodological considerations. Can J Kidney Health Dis (2016) 0.75
Association of serum adiponectin concentration with aortic arterial stiffness in chronic kidney disease: from the KNOW-CKD study. Clin Exp Nephrol (2016) 0.75
Stroke and bleeding in atrial fibrillation with chronic kidney disease. N Engl J Med (2012) 4.69
Progression risk, urinary protein excretion, and treatment effects of angiotensin-converting enzyme inhibitors in nondiabetic kidney disease. J Am Soc Nephrol (2007) 2.00
Long-term mortality and renal outcome in a cohort of 100 patients with lupus nephritis. Arthritis Care Res (Hoboken) (2010) 1.89
Long-term haemodialysis survival. Clin Kidney J (2012) 1.40
Factors influencing the decision to start drug treatment in hypertension. A questionnaire study comparing general practitioners and hypertension specialists in Denmark. Blood Press (2006) 1.40
The rate of progression of renal disease may not be slower in women compared with men: a patient-level meta-analysis. Nephrol Dial Transplant (2003) 1.30
Endothelial dysfunction and reduced nitric oxide in resistance arteries in autosomal-dominant polycystic kidney disease. Kidney Int (2003) 1.29
Improved prognosis in patients with autosomal dominant polycystic kidney disease in Denmark. Clin J Am Soc Nephrol (2010) 1.19
The Danish Registry on Regular Dialysis and Transplantation: completeness and validity of incident patient registration. Nephrol Dial Transplant (2009) 1.19
Asymmetric dimethylarginine, oxidative stress, and vascular nitric oxide synthase in essential hypertension. Am J Physiol Regul Integr Comp Physiol (2008) 1.13
Asymmetric dimethylarginine and lipid peroxidation products in early autosomal dominant polycystic kidney disease. Am J Kidney Dis (2008) 1.08
Changes in causes of death and risk of cancer in Danish patients with autosomal dominant polycystic kidney disease and end-stage renal disease. Nephrol Dial Transplant (2011) 1.06
The effect of angiotensin-converting-enzyme inhibitors on progression of advanced polycystic kidney disease. Kidney Int (2005) 1.02
Low birth weight is associated with earlier onset of end-stage renal disease in Danish patients with autosomal dominant polycystic kidney disease. Kidney Int (2012) 1.01
Regional and social inequalities in chronic renal replacement therapy in Denmark. Nephrol Dial Transplant (2010) 0.96
Beneficial effects on arterial stiffness and pulse-wave reflection of combined enalapril and candesartan in chronic kidney disease--a randomized trial. PLoS One (2012) 0.96
The importance of early referral for the treatment of chronic kidney disease: a Danish nationwide cohort study. BMC Nephrol (2012) 0.90
Estimating glomerular filtration rate using the new CKD-EPI equation and other equations in patients with autosomal dominant polycystic kidney disease. Am J Nephrol (2009) 0.89
Pulse wave reflection is amplified in normotensive patients with autosomal-dominant polycystic kidney disease and normal renal function. Am J Nephrol (2007) 0.87
Feasibility of combined treatment with enalapril and candesartan in advanced chronic kidney disease. Nephrol Dial Transplant (2009) 0.86
Flow-associated dilatory capacity of the brachial artery is intact in early autosomal dominant polycystic kidney disease. Am J Nephrol (2006) 0.85
Less use of standard guideline-based treatment of myocardial infarction in patients with chronic kidney disease: a Danish nation-wide cohort study. Eur Heart J (2013) 0.85
Eplerenone attenuates pulse wave reflection in chronic kidney disease stage 3-4--a randomized controlled study. PLoS One (2013) 0.84
Longitudinal observations on circadian blood pressure variation in chronic kidney disease stages 3-5. Nephrol Dial Transplant (2008) 0.83
Moderate antiproteinuric effect of add-on aldosterone blockade with eplerenone in non-diabetic chronic kidney disease. A randomized cross-over study. PLoS One (2011) 0.83
Impact of the tumor necrosis factor receptor-associated protein 1 (Trap1) on renal DNaseI shutdown and on progression of murine and human lupus nephritis. Am J Pathol (2012) 0.81
Angiotensin AT1-receptor blockers and cerebrovascular protection: do they actually have a cutting edge over angiotensin-converting enzyme inhibitors? Expert Rev Neurother (2009) 0.81
Use of nonsteroidal anti-inflammatory drugs prior to chronic renal replacement therapy initiation: a nationwide study. Pharmacoepidemiol Drug Saf (2012) 0.81
Effect of nephrectomy and captopril on autoregulation of cerebral blood flow in rats. Am J Physiol Heart Circ Physiol (2003) 0.80
Incidence and predictors of end-stage renal disease in outpatients with systolic heart failure. Circ Heart Fail (2013) 0.79
High risk of ischemic heart disease in patients with lupus nephritis. J Rheumatol (2011) 0.79
Silencing of renal DNaseI in murine lupus nephritis imposes exposure of large chromatin fragments and activation of Toll like receptors and the Clec4e. PLoS One (2012) 0.79
Enalapril dosage in progressive chronic nephropathy: a randomised, controlled trial. Eur J Clin Pharmacol (2005) 0.79
Last Word on Point:Counterpoint: Sympathetic nervous activity does/does not influence cerebral blood flow. J Appl Physiol (1985) (2008) 0.79
The expression and activity of renal nitric oxide synthase and circulating nitric oxide in polycystic kidney disease rats. APMIS (2004) 0.79
Ambulatory arterial stiffness index in chronic kidney disease stage 2-5. Reproducibility and relationship with pulse wave parameters and kidney function. Scand J Clin Lab Invest (2012) 0.78
[Microalbuminuria is associated with a fourfold increased risk of ischemic heart disease among hypertensive patients]. Ugeskr Laeger (2002) 0.78
Anti-glomerular basement membrane glomerulonephritis and thrombotic microangiopathy in first degree relatives: a case report. BMC Nephrol (2012) 0.77
Possibly enhanced Gd excretion in dialysate, but no major clinical benefit of 3-5 months of treatment with sodium thiosulfate in late stages of nephrogenic systemic fibrosis. Nephrol Dial Transplant (2008) 0.77
High incidence of secondary hypertension in patients referred for renal denervation--the Copenhagen experience. Blood Press (2014) 0.77
Blood pressure response to conventional and low-dose enalapril in chronic renal failure. Br J Clin Pharmacol (2003) 0.77
Blood pressure lowering in acute ischaemic stroke: an update on the role of angiotensin receptor blockers. J Hypertens (2007) 0.77
Nephrectomy and peritoneal dialysis eliminates circulating renin and controls uraemia in the rat. J Renin Angiotensin Aldosterone Syst (2002) 0.76
How to exhaust your bone marrow. BMJ Case Rep (2013) 0.75
The management of elevated blood pressure in acute stroke: preferential use of angiotensin II receptor antagonists? J Hypertens (2004) 0.75
Reply: Clinical Benefit of Warfarin in Dialysis Patients With Atrial Fibrillation. J Am Coll Cardiol (2015) 0.75
[Renoprotection and blockade of the renin-angiotensin system: What shall we believe?]. Ugeskr Laeger (2006) 0.75
Difficulties in reaching therapeutic goals for hypertension and dysplipidaemia in patients with type 2 diabetes in general practice. Dan Med J (2013) 0.75
[Blockade of the renin-angiotensin system. ACE inhibitors, angiotensin II antagonists or both?]. Ugeskr Laeger (2003) 0.75
[Hypertension and renal disease]. Ugeskr Laeger (2009) 0.75
[Secondary prevention of stroke with effective antihypertensive treatment]. Ugeskr Laeger (2013) 0.75
Effect of Reduced Renal Function on Time in Therapeutic Range Among Anticoagulated Atrial Fibrillation Patients. J Am Coll Cardiol (2017) 0.75
[Dietary protein restriction and chronic renal failure]. Ugeskr Laeger (2003) 0.75
Renal graft failure after addition of an angiotensin II receptor antagonist to an angiotensin-converting enzyme inhibitor: unmasking of an unknown iliac artery stenosis. J Renin Angiotensin Aldosterone Syst (2002) 0.75
Screening for microalbuminuria in patients with type 2 diabetes is incomplete in general practice. Dan Med J (2012) 0.75
[Better treatment of patients with chronic dialysis]. Ugeskr Laeger (2011) 0.75
[A severe case of interstitial nephritis caused by sodium valproate]. Ugeskr Laeger (2006) 0.75
[Hypertension and the brain]. Ugeskr Laeger (2009) 0.75
Limitations of the QuantiFERON-TB Gold test in detecting Mycobacterium tuberculosis infection in immunocompromised patients. Eur J Intern Med (2007) 0.75